Clinical and Economic Value of Genetic Sequencing for Personalized Therapy in Non–small-cell Lung Cancer

Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial

Christophe Le Tourneau, Jean-Pierre Delord, Anthony Gonçalvès et al. · The Lancet Oncology · 2015 · 1.1K citations

Medicine, Oncology, Molecular Oncology +14

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors

Neal I. Lindeman, Philip T. Cagle, Dara L. Aisner et al. · Journal of Thoracic Oncology · 2018 · 633 citations · Full text

Medicine, Molecular Medicine, Oncology +16

Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative

Apostolia M. Tsimberidou, Nancy G. Iskander, David S. Hong et al. · Clinical Cancer Research · 2012 · 541 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Personalized Medicine for Patients with Advanced Cancer in the Phase I Program at MD Anderson: Validation and Landmark Analyses

Apostolia M. Tsimberidou, Sijin Wen, David S. Hong et al. · Clinical Cancer Research · 2014 · 211 citations · Full text

Medicine, Biostatistics, Oncology +17

Genomic Profiling of Advanced Non–Small Cell Lung Cancer in Community Settings: Gaps and Opportunities

Martin Gutierrez, Kelly Choi, Richard B. Lanman et al. · Clinical Lung Cancer · 2017 · 210 citations

Medicine, Molecular Genetics, Oncology +17